| E |
|
Early Anticoagulation for Prevention and Therapy of Deep Venous Thrombosis In Patients Undergoing Craniotomy For Brain Tumor – Risk of Postoperative Intra-cranial Hemorrhage in a Prospective Long-term Study
|
| Bahr W, van den Berg E, van Eck ATCJ, Schmutzler-Baas A, Hamacher J, Ulrich F |
| |
|
Early Control of the First Stage of the Baboon Response to LD100 E. Coli Optimizes the Efficacy and Demonstrates an Antiinflammatory Effect of APC
|
| Taylor F |
| |
|
Early FVIII Exposure and Subsequent Inhibitor Development in Children with Severe Haemophilia A
|
| Chalmers EA, Williams MD, Richards M, Brown SA, Liesner R, Thomas A, Vidler V, Keeling D, Smith D, Hill FGH |
| |
|
Early Use of Low-Molecular-Weight or Unfractionated Heparin in Patients with Non-ST-Segment Elevation Myocardial Infarction and Unstable Angina. The Global Registry of Acute Coronary Events
|
| Brieger D, Gore JM, Goldberg RJ, Spencer F, DiBenedetto D, Eagle KA, Steg PG, Allegrone J, Fox KAA |
| |
|
Ecarin Clotting Time Profile of TGN 255, a Novel Synthetic Intravenous Direct Thrombin Inhibitor
|
| Chahwala S, Chander C, Blackney M |
| |
|
Effect of F7 Gene Promoter Polymorphisms on Factor VII Antigenic Levels
|
| Santamaría A, Sabater-Leal M, Soria JM, Martinez-Marchan E, Almasy L, Blangero J, Jordi F |
| |
|
Effect of 1,6-anhydro Bicyclic Ring Structure on the Antithrombotic Actions of Low Molecular Weight Heparins as Studied in Animal Models of Thrombosis
|
|
| |
|
Effect of 1,6-Anhydro Bicyclic Ring Structure on the Pharmacokinetic and Pharmacodynamic Behavior of Low Molecular Weight Heparin
|
| Jeske WP, Neville B, Ma Q, Hoppensteadt DA, Fareed J |
| |
|
Effect of Age on the Performance of a Diagnostic Strategy Based on Clinical Probability, Spiral CT and Venous Compression Ultrasonography: The ESSEP Study
|
| Couturad F, Parent F, Meyer G, Girard P, Le Gal G, Musset D, Simonneau G, Mottier D, Leroyer C |
| |
|
Effect of Alcohol on Intracellular PH in Human Umbilical Cord Blood CD34+ Stem Cells
|
| Loh S, Chen M, Chen W, Tsai C |
| |
|
Effect of Atorvastatin on Markers of Inflammation and Platelet Aggregation in Patients with Chronic Heart Failure
|
| Korzh O, Kotchuev G, Krasnokutskiy S |
| |
|
Effect Of BAY 59-7939 – A Novel, Oral, Direct Factor Xa Inhibitor – on Clot-Bound Factor Xa Activity in vitro
|
| Depasse F, Busson J, Mnich J, Le Flem L, Gerotziafas GT, Samama MM |
| |
|
Effect of Beer, Dealcoholized Beer and Ethanol Consumption on Hemostasis in Humans
|
| Bassus S, Mahnel R, Scholz T, Wegert W, Westrup D, Kirchmaier CM |
| |
|
Effect of Blood Salvage and Re-infusion on VTE Complications in Patients Undergoing Elective Major Orthopedic Surgery
|
| Filippucci E, Agnelli G, Gallus AS, Anderson Jr FA, FitzGerald G |
| |
|
Effect of Chemotherapeutic Agents on the Protein C Anticoagulant Pathway
|
| Shin L, Woodley-Cook J, Caruso S, Beaudin S, Liaw P |
| |
|
Effect of Cigarrette Smoking on Fibrinogen and Von Willebrand Factor and Their Association with Risk Factors for Microangiopathy
|
| Domenech P, Vilarrasa N, Pina E, Arnan M, Dabrio CG, Montanya E |
| |
|
Effect of Enoxaparin on the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BAY 59-7939 – an Oral, Direct Factor Xa Inhibitor
|
| Kubitza D, Becka M, Voith B, Zuehlsdorf M |
| |
|
Effect of Food and Pantoprazole on the Bioavailability of the Direct Thrombin Inhibitor Dabigatran in Healthy Subjects
|
| Stangier J, Stähle H, Rathgen K |
| |
|
Effect of GpIIb-IIIa on the Point of Care Coagulation Tests in Patients Undergoing Percutaneous Coronary Intervention (PCI)
|
| El Rouby S, Cohen M, Gonzales A, Hoppensteadt D, Zucker M, Lee T, Khalid K, Fareed J, LaDuca F |
| |
|
Effect of Heparanase on TF Expression and TFPI Release
|
| Nadir Y, Brenner B, Zetser A, Ilan N, Goldshmidt O, Vlodavsky I |
| |
|
Effect of Ketoconazole on the Pharmacokinetics and Pharmacodynamics of CS-747 (Prasugrel, LY640315) and Clopidogrel in Healthy Subjects
|
| Farid NA, Payne CD, Winters KJ, Small DS, Brandt JT, Ernest CS, Darstein C, Jakubowski JA, Naganuma H, Salazar D |
| |
|
Effect of Leg Exercises on Popliteal Venous Blood Flow During Prolonged Immobility of Seated Subjects: Implications for Prevention of Travel Related Deep Vein Thrombosis
|
| Cannon M, Cannon S, Garth S, Hitos K, Fletcher J |
| |
|
Effect of Mechanical Ventilation on the Hemostatic State of the Newborn
|
| Chan AKC, Berry LR, Lau A, Parmar N, Jayasuriya K, Roth M, Post M, Belik J |
| |
|
Effect of Modified Normothrombotic Heparin on Cancer Progression and Metastasis
|
| Niers TM, Brüggemann LW, Dinisio M, Spek CA, Van Noorden CR, Büller HR, Reitsma PH, Richel DJ |
| |
|
Effect of Oral Contraceptives on the Anticoagulant Activity of Protein S in Plasma
|
| Koenen RR, Christella M, Thomassen LGD, Tans G, Rosing J, Hackeng TM |
| |
|
Effect of Oxidative Stress on the Circulating Level of Type IV Collagenases and Their Inhibitors in Hemodialyzed Patients with Cardiovascular Disease
|
| Pawlak D, Pawlak K, My[sacute]liwiec M |
| |
|
Effect of Paclitaxel on the Coagulation/Fibrinolytic System Pattern in Cancer and Host's Tumor-Associated Cells
|
| Donati M, Napoleone E, Di Santo A, Amore C, Lorenzet R |
| |
|
Effect of Protein C and Activated Protein C on Alveolar Fibrin Deposition and Turnover in a Piglet Model of Septic Shock
|
| Veldman A, Fischer D, Nold M, Münster A-MB |
| |
|
Effect of Recombinant Factor VIIa or Activated Prothrombin Complex Concentrate on the Bleeding Time in Anaesthetized Rats during Anticoagulant Treatment with the Direct Thrombin Inhibitor Dabigatran
|
| Wienen W, Ruehl D, Stassen JM, Priepke H, Ries UJ, Hauel N |
| |
|
Effect of Regular Sports Activities on the Risk of Venous Thrombosis: Results from the MEGA Study
|
| Van Stralen KJ, Doggen CJM, Rosendaal FR |
| |
|
Effect of rFVIIa Following Experimental Hemodilution with Two Different Colloids in a Rabbit Cuticle Bleeding Model
|
| Lauritzen B, Viuff D, Tranholm M, Rojkjaer R |
| |
|
Effect of Sample Collection Conditions on Interleukin-18, Serum Amyloid – A and Monocyte Chemo-Attractant Protein-1 ELISA Measurement in Human Serum
|
| Wentworth S, Beveridge M, Lauzon M, Johnston M |
| |
|
Effect of Statins on Clopidogrel Platelet Inhibition as Measured by ADP Induced Platelet Aggregation and RPFA-P2Y12 (Accumetrics) in Healthy Volunteers
|
| Reber G, Fontana P, Senouf D, Boehlen F, Mach F, de Moerloose P |
| |
|
Effect of Stress on Total Plasma Homocystein Concentration in Rats
|
| Alisievitch S, Pavlova N, Tcherkasova K, Romanova E, Rudko I, Kubatiev A |
| |
|
Effect of TGN 255, a Novel Intravenous Direct Thrombin Inhibitor, on the Prolongation of ACT in Patients Undergoing Haemodialysis
|
| Combe S, D'Souza R, Mysliwiec M, Padmanabhan N, Sulowicz W, Thomas M, Villa G, Wiecek A, Patrick G, Kennedy A |
| |
|
Effect of the 807C/T Polymorphism in Platelet Glycoprotein Ia on the Relationship between Carotid Artery Intima-Media Thickness and Platelet Activation
|
| Lukasik M, Luzak B, Watala C, Kozubski W |
| |
|
Effect of Thiosulfinates on Calpain and the Platelet Release Machinery
|
| Badol P, Whiteheart SW, Rendu F |
| |
|
Effect of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) and Pancreatic Carboxypeptidase B (CPB) on the Capillary Tube Formation in an in vitro Angiogenesis System
|
| Guimarães AHC, Laurens N, Rijken DC, van Hinsbergh VWM |
| |
|
Effect of YC-1, a cGMP-dependent Manner, on Heterotypic Cell–Cell Interaction: The Study on Neutrophil-platelet Adhesion
|
| Liao CH, Cheng JT, Teng CM |
| |
|
Effect on the Tissue Factor Pathway of Cessation of Warfarin Anticoagulant Therapy
|
| Needham J, Taylor J, Mainwaring J, Blann A, Morrissey J, McLellan D |
| |
|
Effective Anticoagulation Self-Management in a Diverse Population of Oral Anticoagulation Patients Using the Protime System
|
| El Rouby S, Zucker ML, Ruybalid L, Gunnemann T, LaDuca FM, Jacobson A |
| |
|
Effective Inhibition of Platelet Aggregation and Release Reaction with Lack of Effect on Shape Change by CS-747 (Prasugrel, LY640315) and Its Active Metabolite
|
| Ogawa T, Sugidachi A, Isobe T, Shimoji T, Suzuki N, Maeda N, Matsushita Y, Jakubowski JA, Asai F |
| |
|
Effective Venous Thromboembolic Risk Assessment in Pregnancy Allows Appropriate Thromboprophylaxis: a Prospective Outcomes Study
|
| Farren T, Coleman M, Taylor E, Arya R, O'Shaughnessy D |
| |
|
Effectiveness of Anticoagulant Thromboprophylaxis in Medical Diagnostic/Speciality Subgroups: A Meta-Analysis of Randomised Clinical Trials
|
| Cohen AT, Davis EF |
| |
|
Effectiveness of Recombinant Activated FVII (rFVIIa) for the Treatment of Severe Bleeding Episodes in Pediatric Patients
|
| Vyas H, Kulkarni R, Guertin S, Fath J |
| |
|
Effects of Acidosis and Hypothermia on Whole Blood Clotting Function in Swine
|
| Pusateri AE, Delgado AV, Martini WZ, Uscilowicz JM, Christensen SE |
| |
|
Effects of Acute Hyperglycaemia on Platelet and Leukocyte Activation: Involvement of Multiple Mechanisms
|
| Sudic D, Razmara M, Forslund M, Ji Q, Hjemdahl P, Li N |
| |
|
Effects of Angiotensin-(1–7) on the Expression of Tissue Factor Induced by Angiotensin II and its Mechanisms in Vascular Endothelial Cells
|
| Zhang H, Wen ZB, He XF, He SL |
| |
|
Effects of Arginine Vasopressin 2 Receptor Polymorphisms on von Willebrand Factor and Factor VIII Levels and the Risk for Venous Thrombosis
|
| Nossent AY, Vos HL, Rosendaal FR, Bertina RM, Eikenboom HCJ |
| |
|
Effects of Arginine Vasopressin 2 Receptor Polymorphisms on von Willebrand Factor and Factor VIII Levels and the Risk for Venous Thrombosis
|
| Nossent AY, Vos HL, Rosendaal FR, Bertina RM, Eikenboom HCJ |
| |
|
Effects of Base Therapy on Coagulation Haemostasis in Patients with Ischemic Heart Diseases Complicated with Chronic Heart Failure
|
| Mirsamatova G |
| |
|
Effects of Clopidogrel on the Rebound Hypercoagulable State in Acute Coronary Syndromes (ACS) Patients after Heparin Discontinuation
|
| Di Nisio M, Bijsterveld NR, Meijers JCM, Levi M, Büller HR, Peters RJG |
| |
|
Effects of Daclizumab on Lymphocyte-Endothelial Cell Activity in Patients with Chronic-Graft-Versus-Host Disease
|
| Kaushal V, Mehta P |
| |
|
Effects of G-CSF/SCF on Cardiac Function and Cellular Repair Processes after Acute Myocardial Infarction
|
| Bobik A, Kanellakis P, Jane S, Curtis D |
| |
|
Effects of Granulocyte-Colony Stimulating Factor on Platelet and Leukocyte Function in Whole Blood in vitro
|
| Zhao L, Sprigg N, Heptinstall S, Bath PMW |
| |
|
Effects of Heparins on the Anticoagulant Function of Endothelial Tissue Factor Pathway Inhibitor (TFPI)
|
| Brodin E, Iversen N, Østergaard P, Hansen JB |
| |
|
Effects of Highly Active Antiretroviral Therapy on the Risk of Venous and Arterial Thromboembolism in Male and Female HIV Positive Patients
|
| Ten Kate MK, Brouwer JLP, Sprenger HG, Van der Meulen PA, Van der Meer J |
| |
|
Effects of Hyperhomocysteinemia on the Anticoagulant System and Platelet Function Under Stress
|
| Pavlova N, Cherkasova K, Rudko I, Romanova E, Kubatiev A |
| |
|
Effects of Hypothermia and Acidosis on Swine Platelet Activation and Aggregation in vivo
|
| Delgado AV, Dong JF, Chambers JP, Pusateri AE |
| |
|
Effects of Improved Metabolic Control on Platelet Reactivity in Patients with Type 2 Diabetes Mellitus Following Coronary Angioplasty
|
| Yngen M, Norhammar A, Daleskog M, Johansson M-C, Hjemdahl P, Wallén NH |
| |
|
Effects of Leptospiral Proteins on Human Endothelial Cells
|
| Schattner M, Negrotto S, Gamberini M, Von Atzinger M, Leite L, Martins E, Ho P, Gómez RM, Nascimento AL |
| |
|
Effects of Long-Term Simvastatin Treatment on Some Hemostatic Parameters in Hyperlipidemic Patients with Ischemic Heart Disease
|
| Malyszko JS, Stogowska B, Malyszko J, Mysliwiec M |
| |
|
Effects of Oral Hormone Replacement Therapy (HRT) on Platelet Function, Inflammatory Markers and Matrix Metalloproteinases in Postmenopausal Women with Established Coronary Artery Disease
|
| Wallen NH, Li N, Eriksson-Berg M, Daleskog M, Johansson MC, Hjemdahl P |
| |
|
Effects of Plasma Dilution with Crystalloid or Colloid Solutions on Blood Coagulation
|
| Sinauridze E, Gorbatenko A, Bulanov A |
| |
|
Effects of Recombinant Activated Factor VII on Perilesional Oedema in Patients with Acute Intracerebral Haemorrhage
|
| Diringer MN, Davalos A, Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Skolnick BE, Steiner T |
| |
|
Effects of Recombinant Antithrombin Expressed in Chinese Hamster Ovary Cells on Endotoxin- or Thromboplastin-Induced DIC in Rats and Concanavalin A-Induced Liver Injury in Mice
|
| Tsukada M, Shintani N, Kubo Y, Hirayama F, Iwamoto M, Miyano K, Kondo M, Hirose M, Ohi H |
| |
|
Effects of Siwu Tang on the Tissue Factor Expression of Astrocytes from Neonatal Rat
|
| He XF, Wen ZB, He SL |
| |
|
Effects of Temperature and Shear on COAT-Platelets Generation
|
| Colucci G, Alberio L |
| |
|
Effects of the Direct Thrombin Inhibitor Argatroban, Demographic Variables, and Platelet Count on Thrombotic Risks in Heparin-Induced Thrombocytopenia
|
| Lewis BE, Wallis DE, Hursting MJ, Levine RL, Fareed J, Katz E, McCollum D |
| |
|
Effects of the Pan-Selectin Antagonist Bimosiamose (TBC1269) on LPS Induced Coagulation
|
| Mayr FB, Spiel A, Leitner JM, Firbas C, Reiter R, Jilma B |
| |
|
Effects of Warfarin Administration on in vivo Revascularization in a Rat Model of Hindlimb Ischemia
|
| De Paula EV, Ramos CD, Ozelo MC, Machado TF, Guillaumon AT, Garcia RA, Annichino-Bizzacchi JM, Arruda VR |
| |
|
Efficacy and Safety of FEIBA VH Prophylaxis in a Patient with Hemophilia B and a High-Titer Inhibitor
|
| Valentino L |
| |
|
Efficacy of the PFA-100® as a Screening Tool for Platelet Dysfunction
|
| Vu L, Demers C, Cloutier S |
| |
|
Efficacy, Safety and Pharmacokinetic Properties of ADVATE rAHF-PFM in Previously Treated Patients (PTPs) Less Than 6 years of Age
|
| Liesner R, Shapiro A, Blanchette V, Hernandez F, Warrier I, Retzios A, Schroth P, Seltmann M, Spotts G, Ewenstein B |
| |
|
Efficiency of TSE Elimination By Coagulation Factor Manufacturing Processes
|
| Chtourou S, Flan B |
| |
|
Efficient Reduction of Prions by the Manufacturing Process of Plasma-Derived Products
|
| Schafer W, Bodenbender W, Gnau O, seyfert-Brandt W, Wiegand T, Vey M, Groner A |
| |
|
Egr-1: A Key Mediator of Oscillatory Shear Stress Induction of Tissue Factor Promoter
|
| Mazzolai L, Bouzourene K, Mackman N, Hayoz D, Silacci P |
| |
|
Eight Novel Mutations in FXI Gene
|
| Castaman G, Ghiotto R, Rossetti G, Habart D, Tagliaferri A, Tosetto A, Duga S |
| |
|
Electrostatic Properties of Naturally Occurring Protein C Mutants by Computational Analysis
|
| Faioni EM, D'Ursi P, Merati G, Biguzzi E, Rovida E |
| |
|
Elevated Alpha 1-Antitrypsin Is a Risk Factor for Arterial Ischemic Stroke in Childhood
|
| Burghaus B, Langer C, Thedieck S, Nowak-Göttl U |
| |
|
Elevated Coagulation Factor VIII and Free Flap Failure after Late Breast Reconstruction with a TRAM Flap
|
| Höijer P, Olsson E |
| |
|
Elevated Factor IX, XI and XII-Activities Are Associated with an Increased Risk for Venous Thrombosis
|
| Schmitt J, Humpich M, Luxembourg B, Seifried E, Lindhoff-Last E |
| |
|
Elevated Gas6 Plasma Levels in Patients with Severe Sepsis
|
| D Borgel D, Clauser S, Bornstain C, Bièche I, Bissery A, Remones V, Fagon JY, Aiach M, Diehl JL |
| |
|
Elevated Levels of Interleukin-10 and the IL-10 -819 C/T SNP Are Predictors of Poor Prognosis in Patients with Acute Coronary Syndrome
|
| Siegbahn A, Lindahl B, Wallentin L, Mälarstig A |
| |
|
Elevated Nitric Oxide Levels with Brachytherapy Compared to Bare Metal or Sirolimus Eluting Stents. Implications in Coronary Restenosis
|
| Fareed D, Iqbal O, Jeske W, Leya F, Walenga J, Hoppensteadt D, Fareed J |
| |
|
Elevated Plasma Levels of High Sensitivity C-Reactive Protein in Patients with Coronary Bridge and No Significant Coronary Stenosis
|
| Jong G-P, Ma T, Kuo S-D |
| |
|
Elevated Platelet Count Increases the Risk of Thromboembolism during Outpatient Chemotherapy
|
| Khorana AA, Francis CW, Culakova E, Lyman GH |
| |
|
Elevated Platelet Delivered Microparticles and Lesion Morphology in Acute Coronary Syndrome
|
| Tanaka A, Namba M, Ozeki Y, Uehata S, Nishida Y, Sakamoto T, Nomura S |
| |
|
Elevated Prothrombin Fragment F1 + 2 Levels during Pregnancy in Women with Previous Venous Thromboembolism
|
| Zotz RB, Gerhardt A, Marzotko S, Wagner KJ, Bender HG, Scharf RE |
| |
|
Elevated Serum Nerve Growth Factor (NGF) Levels in Patients with Acute Leukemia and Lymphoma Especially with CNS Involvement
|
| Elbaz O, Mansour A, Fouda M, Aboelfetoh N |
| |
|
Elevation of Thrombotic Biomarkers Reveals the Prothrombotic State of Genetically Diabetic (db/db) and Obese (ob/ob) Mice
|
| Arey BJ, Normandin D, Feyen JHM, Youssef S, Ogletree ML |
| |
|
ELISA for Detecting Immune Responses to Factor VIII
|
| Sahud MA, Pratt KP, Zhukov O, Qu K, Nakaya SM, Thompson AR |
| |
|
Elucidation of the Binding Regions of TAFI Neutralising Antibodies Reveals Different Molecular Targets for Thrombin vs Plasmin Mediated TAFI Activation
|
| Gils A, Ceresa E, Deliu A, Marx P, Peeters M, Compernolle G, Declerck PJ |
| |
|
Embolic Stroke in Factor XI Deficiency after Recombinant Factor VIIa Use
|
| Boggio L |
| |
|
Endocannabinoid Anandamide Induces High Mobility Group Box 1 (HMGB1) Protein Release in Monocytes and Macrophages
|
| Biswas KK, Sarker KP, Kawahara K, Abeyama K, Hashiguchi T, Yamada S, Maruyama I |
| |
|
Endogenous Myocardial FVIII:C, von Willebrand Factor (vWF) and Fibrinogen Are Independent of Regional Myocardial Blood Flow (RMBF)
|
| Loncar R, Decking UM, Stoldt V, Scharf RE |
| |
|
Endogenous Tissue-Type Plasminogen Activator Is Essential for an Adequate Host Defense During 
Induced Abdominal Sepsis
|
| Renckens R, Roelofs JJTH, Lijnen HR, van't Veer C, van der Poll T |
| |
|
Endoplasmic Reticulum-Associated Degradation of Naturally Occurring Protein C and Plasmin Inhibitor Mutants
|
| Nishio M, Koyama T, Nakahara M, Hirosawa S |
| |
|
Endothelial and Platelet Function in Healthy Human Volunteers Treated with Pregabalin: Implications for the Development of Haemangiosarcoma Seen in Mice
|
| Chatamra K, Phillips S, Ralis HM, Jennings GM, Davies DA, Giddings JC |
| |
|
Endothelial Dysfunction and Atherogenesis Are Induced by Chronic Carbon Disulfide (CS2) Exposure
|
| Teplyakov AI, Teplyakova DV, Kruchinsky NG |
| |
|
Endothelial Microparticle Binding to Neutrophils Is an Important Determinant of Neutrophil Activation In Vivo in Different Clinical Conditions
|
| Chirinos JA, Castrellon A, Soriano AO, Arteaga R, Heresi GA, Velásquez H, Jy W, Jiménez JJ, Horstman LL, Ahn E, Ahn YS |
| |
|
Endothelial Microparticle Elevation in Uremia: A New Aspect of Endothelial Dysfunction Related to Uremic Toxins
|
| Faure V, Dou L, Sabatier F, Cerini C, Sampol J, Berland Y, Brunet P, Dignat-George F |
| |
|
Endothelial Progenitor Cells Are Mobilized Following Coronary Angiography
|
| Millar CG, Stirling D, Mills N, Newby D, Ludlam CA |
| |
|
Endothelial Progenitor Cells for Regeneration
|
| Asahara T |
| |
|
Endothelial Protein C Receptor (EPCR) Gene Polymorphisms and sEPCR Levels in Women with Recurrent Pregnancy Loss
|
| Sarig G, Bercovich D, Levi D, Shochat C, Tenenbaum G, Brenner B |
| |
|
Endothelial Protein C Receptor Is Expressed by CD83+ Dendritic Cells in the Human Gut Mucosa and Is Down-Regulated by Bacterial Antigens on Monocyte-Derived Dendritic Cells
|
| Faioni EM, Ferrero S, Fontana G, Gianelli U, Doi P, Rescigno M, Salucci V, Bosari S, Cattaneo M |
| |
|
Endotheliumdependent Factors of Haemostasis and Fibrinolysis in Some Renal Diseases
|
| Podorolskaya L, Lisenko L, Polyantseva L, Bobkova I, Andreenko G |
| |
|
Endotoxemia Induces Factor VIII-mediated Resistance to Activated Protein C in Healthy Humans
|
| de Pont AC, Bakhtiari K, Hutten BA, de Jonge E, van der Poll T, Büller HR, Levi M, Meijers JCM |
| |
|
Engineering of a Recombinant Vitamin K-Dependent Gamma-Carboxylation System with Enhanced Gamma-Carboxyglutamic Acid (Gla) Forming Capacity. Evidence for a Functional CXXC RedOx Center in the System
|
| Wajih N, Sane CD, Hutson SM, Wallin R |
| |
|
Enhanced Antiplatelet Effect of Clopidogrel in Patients with Aspirin Resistance: A Randomized Crossover Trial
|
| Eikelboom JW, Hankey GJ, Thom J, Claxton A, Yi Q, Gilmore G, Staton J, Barden A, Norman PE |
| |
|
Enhanced Blood Coagulation and Fibrinolysis in Mice Lacking Histidine-Rich Glycoprotein/HRG
|
| Tsuchida-Straeten N, Ensslen S, SchäferWöltje CM, Denecke B, Moser M, Gräber S, Wakabayashi S, Koide T, Jahnen-Dechent W |
| |
|
Enhanced Platelet Aggregation and Thrombogenic Tendency in Adiponectin-Deficient Mice
|
| Kato H, Kashiwagim H, Shiraga M, Tadokoro S, Kamae T, Honda S, Miyata S, Yamamoto J, Kurata Y, Funahashi T, Shimomura I, Tomiyama Y, Kanakura Y |
| |
|
Enhanced Shear-Induced Platelet Aggregation in Patients Who Experienced Subacute Stent Thrombosis: A Case-Control Study
|
| Ajzenberg N, Aubry P, Huisse MG, Cachier A, El Amara W, Feldman LJ, Himbert D, Baruch D, Guillin MC, Steg PG |
| |
|
Enhancement of Catalytic Activities of Thrombin and Trypsin By Human Insulin
|
| Poyarkova SA, Baklan TN, Lazarev AP |
| |
|
eNOS Gene Affects Blood Viscosity and Red Cell Deformability: Role of eNOS T-786C, G894T and 4a/4b Polymorphisms
|
| Mannini L, Fatini C, Sticchi E, Lapini I, Bigi P, Leporini E, Pagnini P, Gensini GF, Prisco D, Abbate R |
| |
|
Enoxaparin (E) and Warfarin (W) Differentially Regulate Tissue Factor (TF), Tissue Factor Pathway Inhibitor (TFPI) and Thrombin Activatable Fibrinolytic Inhibitor (TAFI) in Cancer Patients with Thrombosis
|
| Fareed J, Hoppensteadt D, Iqbal O, Jeske WP, Walenga JM, Dietcher S |
| |
|
Enrichment of Early Megakaryocyte Progenitors and Their Ex-Vivo Expansion for Transplantation
|
| Deutsch V, Hubel E, Pick M, Naparstek E, Katz B, Grisaru D |
| |
|
EPCR Cleavage and inactivation by Neutrophil Proteinase 3
|
| Villegas-Mendez A, Montes R, Lane1 DA |
| |
|
Epidemiological Aspects of Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura In Southern Iran (an Experience of 13 years)
|
| Karimi M, Sabzi A |
| |
|
Epidemiology of Pulmonary Embolism in Elderly Patients Admitted in an Italian Teaching Hospital: Preliminary Data of a Ten years Retrospective Analysis
|
| Masotti L, Cappelli R |
| |
|
Epigenetic Regulation of Tissue Factor Gene Expression
|
| Nakamura S, Okada M |
| |
|
Epitope Mapping During FVIII Inhibitor Eimination With Rituximab Reveals Conformational Epitopes on FVIII and Identifies Small Molecules Blocking Inhibitor and Targeting B Cells
|
| Kessel C, Königs C, Roland J, Linde R, Escuriola C, Stoll H, Figura S, Dunsch D, Dietrich U, Klingebiel T, Kreuz W |
| |
|
Epitope Mapping of Inhibitors in Acquired Haemophilia A
|
| Königs C, Krause M, Roland J, Kessel C, Dietrich U, Scharrer I, Kreuz W |
| |
|
Epitope Mapping of Inhibitory Antibodies and Inhibitor Elimination with Rituximab in Patients with Acquired Haemophilia
|
| Krause M, Königs C, Kessel C, von Auer C, Kreuz W, Scharrer I |
| |
|
Epitope Mapping of the Factor VIII-specific T Cell Response in E-17 Knockout Mice Using Peptide Pool Arrays
|
| Tonn T, Behrmann M, Loeckermann S, Sorg N, Germer M, Kotitschke R, Radeke H, Seifried E |
| |
|
Erk–Mediated Thromboxane A2 Production Is Essential for von Willebrand Factor/GPIb–Induced Fibrinogen Receptor Activation in Human Platelets
|
| Garcia A, Dorsam RT, Kunapuli SP |
| |
|
Essential Role of Junctional Adhesion Molecule-A in bFGF-Induced Angiogenesis
|
| Cooke VG, Naik MU, Skarnes W, Naik UP |
| |
|
Ethical Dilemmas in Haemophilia Care
|
| Chalmers D |
| |
|
Evaluation of a Commercial ELISA Based Assay for Factor XIII A
|
| Brooks SV, Filer K, Riddell A, Brown SA |
| |
|
Evaluation of a Fully Automated Immuno-Turbidimetric Assay to Quantify Free Protein S (HemosIL Free Protein S)
|
| Toulon Pierre A, Giraud Carole |
| |
|
Evaluation of a latex-based D-Dimer-Assay on Clinical Chemistry Analyser Olympus AU 640TM
|
| Eller, Th, Schmitz FJ |
| |
|
Evaluation of a New Factor Xa-based Antithrombin assay
|
| Cooper SM, Cooper PC, Kitchen S, Makris M |
| |
|
Evaluation of a New Manufacturing Process for Therapeutic Fibrinogen
|
| Porte P, Kimmel-Jehan C, Bihoreau N, Sauger A, Chtourou S |
| |
|
Evaluation of a Novel Direct Factor VIIa Inhibitor in Rabbit Models of Arterial Thrombosis and Hemostasis
|
| Wong P, Crain E, Watson C, Staus A, Luettgen J, Rendina A, Abell L, Knabb R, Baomin X, Zhou J, DeLucca I, Priestley E |
| |
|
Evaluation of Aspirin Resistance in Peripheral Arterial Disease
|
| Halawani S, Brittenden J, Bachoo P, Greaves M, Ford I |
| |
|
Evaluation of dHPLC in the Genetic Analysis of Fibrinogen Disorders
|
| Hill M, Harrison SJ, Tait RC, Dolan G |
| |
|
Evaluation of DiaMed Heparin/PF4 Testing for HIT
|
| Gemmell R, Evans S, Monkhouse L, Brighton T |
| |
|
Evaluation of Diamed ID-PaGIA Heparin/PF4 Antibody Test for the Diagnosis Of HITTS
|
| Butler J, Malan E, Gan TE |
| |
|
Evaluation of FEIBAVH in Patients with an Inhibitor and Hemophilic Arthropathy
|
| Hilgartner M |
| |
|
Evaluation of Fibrinolytic Activity and Major Hemorrhages in Probable Type 1 Von Willebrand Disease
|
| Woods AI, Blanco AN, Nadal MV, Meschengieser SS, Grosso SH, Lazzari MA |
| |
|
Evaluation of Fluorogenic Substrates for the Monitoring of Thrombin Generation
|
| Tappenden KA, Gallimore MJ, Mackie IJ, Evans G, Winter M, Jones DW |
| |
|
Evaluation of Gene Expression Profiles in Thrombocytes Using Microarrays
|
| Pudur J |
| |
|
Evaluation of Glass versus Plastic Blood Collection Tubes Used in Coagulation Testing
|
| Plumhoff EA, Schulte SJ, Elliott MA, Nichols WL, Heit JA |
| |
|
Evaluation of GPIIb/IIIa Antagonist YM128 Using Monkeys with Photochemically-Induced Middle Cerebral Artery Occlusions
|
| Kaku S, Moritani Y, Ichihara M, Sasamata M, Miyata K |
| |
|
Evaluation of Hemostasis Changes Between Patients Underwent Coronary Artery Bypass Graft (CABG) with and without Cardiopulmonary Bypass. Partial Results of MASS-III Study
|
| Rached RA, Hueb WA, Cavalheiro-Filho C, Lopes NH, De Piano LPA, Chamone DAF, Ramires JAF, Oliveira SA |
| |
|
Evaluation of Hemostasis Changes in Patients Underwent Coronary Artery Bypass Graft (CABG). The Partial Results in a Brazilian Hospital
|
| LPA De Piano, RA Rached, WA Hueb, C Cavalheiro-Filho, CN Andrade, DAF Chamone, SA Oliveira |
| |
|
Evaluation of Low Molecular Weight Heparin Anticoagulation during Hemodialysis with Sonoclot Coagulation Analysis
|
| Schött U |
| |
|
Evaluation of PAI-1 Inhibitors in the Microcirculation of the Hamster Cheek Pouch
|
| Verbeuren TJ, Vallez MO, de Nanteuil G, Baudry O, Rupin A |
| |
|
Evaluation of Pro-Angiogenic Activity of Factor XIII (FXIII) in Murine Models of Heart Transplantation and FXIII-Deficient Mice
|
| Inbal A, Leor J, Castel D, Holbova R, Schibi G, Dickneite G, Dardik R |
| |
|
Evaluation of Pro-angiogenic and Pro-Coagulant Activity of Irradiated, Non Irradiated and Filtered Stored Blood Used in Transfusion Practice
|
| Inbal A, Yeskaraev R, Hekmatian N, Achiron A, Livnat T, Harari G, Mandel M |
| |
|
Evaluation of Shape Change in Chilled Blood Platelet Using Light Scattering
|
| Tani Y, Terada C, Tanaka S, Hori Y, Hayashi T, Hirayama F, Shibata H |
| |
|
Evaluation of Stability of Sucrose – Formulated, Full-Length Rfviii for Use in Continuous Infusion Therapy
|
| Uri M, Aaron L, Ilia T, Jacob L |
| |
|
Evaluation of the Anticoagulant Effect of Enoxaparin by Using Clot Based Point of Care Tests
|
| Diez J, El Rouby S, Hoppensteadt D, Bowers S, Zucker M, Fareed J, LaDuca F |
| |
|
Evaluation of the Automated Coagulation Analyzer ACL TOPTM
|
| Handler S, Guschlbauer E, Quehenberger P |
| |
|
Evaluation of the New ACL TOP Coagulation Analyser from IL
|
| M Morelli B, Stefanin C, Cozzi MG, Duca ML, Garghetti E, Rampinini F, Spagnotto M |
| |
|
Evaluation of the Quality of Oral Anticoagulation Management in an Anticoagulation Clinic (ACC)
|
| Lee LH, Kong MC, Lee ACC members PL |
| |
|
Evaluation of the Relationship between Free Protein S Levels and Thrombin Generation during Pregnancy
|
| McRae SJ, Cloutier S, Bates SM, Johnston M, Ginsberg JS |
| |
|
Evaluation of the Roles of Rac1 and Rac2 in Lamellipodia and Aggregate Formation on Collagen Under Flow
|
| Auger JM, McCarty OJT, Larson MK, Ruf S, Henderson RB, Machesky LM, Tybulewicz VLJ, Watson SP |
| |
|
Evaluation of the Warkentin 4 T's Clinical Prediction Tool for Heparin-Induced Thrombocytopenia (HIT): Comparison to the Chong's HIT Classification Score
|
| Dager W, Lee A, Gosselin R, King J, Wun T, Janatpur K, Owings J, White R |
| |
|
Evaluation of Thirdwave Invader® DNA Analysis Compared to Multiplex PCR Analysis for the Detection of Factor VLeiden and Prothrombin 3'UTR Gene Mutations
|
| Riddell A, Mellars G, Perry DJ |
| |
|
Evaluation of Thrombotic Events in Haemophiliacs Undergoing Major Orthopaedic Surgery without Thrombosis Prophylaxis
|
| Krause M, von Auer C, Kurth A, Ashmelash G, Hovy L, Scharrer I |
| |
|
Evidence for a Critical Role of the Modifying Subunit of Glutamatecysteine Ligase in Homocysteine Pathophysiology
|
| Heil SG, Kluijtmans LAJ, De Vriese AS, den Heijer M, Pfundt R, Blom HJ |
| |
|
Evidence for Loci Pleotropically Influencing Inter-Related Clotting Factors
|
| Vossen CY, Callas PW, Rosendaal FR, Hasstedt SJ, Scott BT, Long GL, Bovill EG |
| |
|
Evidence for the Anit-thrombotic Efficacy of Potato Carboxypeptidase Inhibitor in a Mouse Model of Ferric Chloride-Induced Venous Thrombosis
|
| Wang X, Smith P, Hsu M-Y, Schumacher W |
| |
|
Evidence of a Critical Role for F11R (a.k.a. JAM-1) in the Adhesion of Platelets to the Endothelium at the Onset of Inflammatory Thrombosis
|
| Babinska A, Liu R, Jiang X-C, Ehrlich YH, Kornecki E |
| |
|
Evidence of Normal Thrombin Generation in Cirrhosis Despite Abnormal Conventional Coagulation Tests
|
| Tripodi A, Salerno F, Chantarangkul V, Clerici M, Cazzaniga M, Primignani M, Mannucci PM |
| |
|
Evidence of Partial P2Y12 Receptor Antagonism Despite Excess Clopidogrel in Mice
|
| Crosdale DJ, Francis SE, Norman KE, Storey RF |
| |
|
Evidence Suggesting That Activated Platelets Induce APC-Resistance in Vivo
|
| Leone M, Momi S, Colucci M, Gresele P |
| |
|
Evidence That the Holes in Immobilized Fibrinogen Are Always Available
|
| Hársfalvi J, Deckmyn H |
| |
|
Evidences for Vascular Endothelium Damage/Proliferation and Abnormal Neoangiogenesis by Endothelial Growth Factor (VEGF), Platelet Derived Growth Factor (PDGF), Interleukin-6 (IL-6) Increased Levels in Sickle Cell Disease
|
| Musso R, Cultrera D, Meo A, Musso M, Cipolla A, Giustolisi R |
| |
|
Evolution of Antithrombin (AT) and Fibrinogen (Fg) Levels during Induction Chemotherapy with L-asparaginase (Asp) in Adult Patients with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL). Clinical Outcomes and Use of Coagulation Supportive Treatments: The CAPELAL Study
|
| Hunault-Berger M, Gruel Y, Harousseau JL, Delain4 M, Maakaroun2 M, Bulabois5 CE, Witz F, Bernard M, Lafon I, Cornillon J, Ladouzi A, Tizon A, Padrazzi B, Tellier Z, Ifrah N |
| |
|
Evolving Risk for Thromboembolism in Spinal Cord Injury
|
| Green D, Soltysik RC, Yarnold PR |
| |
|
Ex Vivo Studies of the Effect of Lupus Anticoagulant on Heparin Monitoring
|
| Trenfield S, Parmar K, Hunt BJ |
| |
|
Examination of Four Acute Arterial Thrombosis Whose Thrombus Dissolution Treatment by Arterial Catheter was Effective
|
| Minagawa Y |
| |
|
Exercise-Induced Deep Vein Thrombosis of the Upper Extremity in Children: Management and Outcome in a Small Series
|
| Ryan C, Williams S, Kahr W, Chan A, Castle D, Floros G, Brandão LR |
| |
|
Experience of Surgery with Continuous Infusion at Karolinska University Hospital in Patients With Hemophilia A and B, von Willebrand'S Disease and FVII-Deficiency
|
| Holmström M, Loogna K, Elfvinge P, Svennefalk M, Naslin D, Schulman S |
| |
|
Experimental Hyperhomocysteinemia Has No Significant Effect on Global Hemodynamics or Regional Myocardial Blood Flow
|
| Loncar R, Scharf RE |
| |
|
Experimental Metastasis and Tumor Cell-Induced Coagulopathy in Mice with Hemophilia A and the Effect of FVIII Replacement Therapy
|
| Langer F, Amirkhosravi A, Walker JM, Ingersoll S, Spath B, Francis JL, Eifrig B |
| |
|
Exploring New Molecules and Activities from Lonomia Obliqua Caterpillar Bristles Extract
|
| Chudzinski-Tavassi AM, Reis CV, Flores MPA, Pereira ALM, Fritzen M |
| |
|
Exposure to Diesel Nanoparticles Does Not Induce Blood Hypercoagulability in an at-Risk Population
|
| Hermans C, BlombergTörnqvist AH, Desmyter L, Deneys V, Wallemacq P, Bernard A |
| |
|
Expression and Characterization of Rat TAFI
|
| Hillmayer K, Deliu A, Compernolle G, Declerck PJ, Gils A |
| |
|
Expression and Function of Syndecan-4 in Human Platelets: A Prominent Role for Antithrombin
|
| Kaneider NC, Feistritzer C, Gritti D, Mosheimer BA, Ricevuti G, Patsch JR, Wiedermann CJ |
| |
|
Expression of ADAMTS13 in Normal Renal Cortex and in Thrombotic Thrombocytopenic Purpura
|
| Manea M, Holmberg L, Kristoffersson AC, Hansson S, Karpman D |
| |
|
Expression of GPVI Is Modulated in Endothelial Cells by Different Agonists
|
| Stasiak M, Kralisz U, Cierniewski CS |
| |
|
Expression of Interleukin-1 (IL-1) Alpha Gene and Circulating Levels of Interleukin-6 (IL-6) and Plasminogen Activator Inhibitor-1 (PAI-1): Preliminary Findings of the Indian Atherosclerosis Research Study (IARS)
|
| Rao V, Mukherjee M, Natesha B, Kakkar VV |
| |
|
Expression of Plasminogen Activator Inhibitor-1 and Bax in Porcine Liver Transplantation – Protective Effect of Tauroursodeoxycholic Acid to Apoptosis
|
| Ejiri S, Kurumi Y, Tani T, Eguchi Y |
| |
|
Expression of TFPIb in Normal Human Tissues and Inhibitory Activity on Tissue Factor-Initiated Coagulation Reactions by Recombinant TFPIb from Transfected CHO Cells and Escherichia Coli
|
| Moatti D, Andrade M, Tunstead J, Hathcock J, Nemerson Y |
| |
|
Expression of the Death Receptor Fas (CD95) on Peripheral T Lymphocytes in Correlation with Selected Clotting System Parameters in Non-Small Cell Lung Cancer
|
| Dworakowska D, Bryl E, Soroczynska M, Witkowski JM, Lapinski M, Tomaszewski D, Dworakowski R, Skokowski J, Czestochowska E |
| |
|
Expression of Tissue Factor Pathway Inhibitor-2 by Retrovirus and Its Effects in Rat Glioma Cells Migration and Invasion
|
| Bai X, Fu J, Ding K, Su J, Wang Z, Ruan C |
| |
|
Expression Profiling Reveals Functionally Important Genes and Coordinately Regulated Signalling Pathway Genes During in vitro Angiogenesis
|
| Hahn CN, Su ZJ, Drogemuller CJ, Tsykin A, Waterman SR, Brautigan PJ, Yu S, Kremmidiotis G, Gardner A, Solomon PJ, Goodall GJ, Vadas MA, Gamble JR |
| |
|
Expression, Regulation and Functional Significance of KC Chemokine During Adipose Development and Obesity
|
| Neels JG, Loskutoff DL, Samad F |
| |
|
Extended Out-of-Hospital Low-Molecular-Weight Heparin Prophylaxis Against Venous Thromboembolism in Patients after Cancer Operations: A Meta-Analysis
|
| Rasmussen MS, Wille-Jørgensen P, Jorgensen LN |
| |
|
Extended Thromboprophylaxis with Fondaparinux (Arixtra®) after Major Orthopedic Lower Limb Surgery: The EXPERT Study
|
| Singelyn FJ, Felicissimo P, Piovella F, Rosencher N, Verheyen K |
| |
|
Extensive Jugular and Subclavian Vein Thrombosis after Ovarian Hyperstimulation Syndrome as a Complication of In Vitro Fertilization: A Case Report
|
| Latimer M, McDonald J, Prosser I |
| |
|
Extensive Venous Malformation Associated with Coagulation Abnormality: Treatment with Peginterferon Alfa 2a
|
| von Auer C, Krause M, Miesbach W, Vigh T, Scharrer I |
| |
|
Extracellular Nucleic Acids Serve as Novel Cofactors for Blood Coagulation Via Contact Pathway Activation
|
| Shibamiya A, Kannemeier C, Nakazawa F, Niepmann M, Trusheim H, Koyama T, Engelmann B, Preissner KT |
| |
|
Extracellular RNA Potentiates Factor VII Activating Protease (FSAP)–Mediated Inhibition of Vascular Smooth Muscle Cell Proliferation Induced by Platelet-Derived Growth Factor-BB (PDGF-BB)
|
| Shibamiya A, Tannert-Otto S, Preissner KT, Kanse SM |
| |
|
Extremely High Levels of Thrombospondin-1 in a Patient Afflicted with Rheumatoid Arthritis are Correlated with Activation of the Coagulation and Fibrinolytic Systems
|
| Manns JM, Nguyen H, Beharry N, Uknis AB, DeLa Cadena R |
| |
|
Extremely Poor Quality of Oral Anticoagulation (OAT) Control during the First Three Months after Unprovoked Venous Thromboembolism (VTE) is a Risk Factor for Long Term Recurrence and is Associated with Higher D-Dimer Levels
|
| Palareti G, Legnani C, Cosmi B, Guazzaloca G, Cini M, Mattarozzi S |
| |
